The science-services and instruments provider is expanding operations in the U.S. as companies rearrange manufacturing to avoid new global tariffs. The pharmaceutical industry has long been exempt ...

The science-services and instruments provider is expanding operations in the U.S. as companies rearrange manufacturing to avoid new global tariffs. The pharmaceutical industry has long been exempt ...

In recent days, Boston Scientific announced a forthcoming CFO change, a Cambridge biotech undertook a 1-for-20 reverse stock ...

Thermo Fisher kicked off 2025 with strong Q1 results, banking $10.36 billion in revenue and flexing its R&D muscles. CEO Marc ...

Medical equipment maker Thermo Fisher Scientific on Wednesday cut its annual profit forecast, in anticipation of a potential ...